comparemela.com

Latest Breaking News On - Richard bryce - Page 4 : comparemela.com

Rain Therapeutics Provides Interim Analysis of Phase 2

UPDATE -- Rain Therapeutics Announces Completion of Enrollment in Phase 3 MANTRA Trial for Milademetan in Liposarcoma

04.08.2022 - – Phase 3 MANTRA trial completed enrollment five months ahead of previous guidance – – MANTRA topline data anticipated in 1H 2023 – – Management to host 2Q 2022 Earnings Call today at 5:00 PM Eastern Time – NEWARK, Calif., Aug. 04, 2022 . Seite 1

vimarsana © 2020. All Rights Reserved.